AEPGX
Price
$63.87
Change
-$0.15 (-0.23%)
Updated
Sep 18 closing price
Net Assets
140.03B
OIGNX
Price
$24.62
Change
-$0.05 (-0.20%)
Updated
Sep 18 closing price
Net Assets
3.05B
Interact to see
Advertisement

AEPGX vs OIGNX

AEPGX vs OIGNX Comparison Chart in %
View a ticker or compare two or three
VS
AEPGX vs. OIGNX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a StrongBuy and OIGNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 140B vs. OIGNX (3.05B). AEPGX pays higher dividends than OIGNX: AEPGX (2.48) vs OIGNX (0.21). AEPGX was incepted earlier than OIGNX: AEPGX (42 years) vs OIGNX (26 years). OIGNX (1.40) is less costly to investors than AEPGX (0.83). AEPGX is a more actively managed with annual turnover of: 50.00 vs. OIGNX (34.00). AEPGX has a lower initial minimum investment than OIGNX: AEPGX (250) vs OIGNX (1000). AEPGX annual gain was more profitable for investors over the last year : 2.33 vs. OIGNX (-29.45). AEPGX return over 5 years is better than : -4.71 vs. OIGNX (-52.79).
AEPGXOIGNXAEPGX / OIGNX
Total Expense Ratio0.831.4059%
Annual Report Gross Expense Ratio0.831.4059%
Fund Existence42 years26 years-
Gain YTD5.5531.904292%
Front Load6%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets140B3.05B4,586%
Annual Yield % from dividends2.480.211,191%
Returns for 1 year2.33-29.45-8%
Returns for 3 years27.89-28.89-97%
Returns for 5 years-4.71-52.799%
Returns for 10 years45.00-30.42-148%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFAGX36.570.15
+0.41%
Commerce MidCap Growth
HIACX54.070.13
+0.24%
Hartford Capital Appreciation HLS IA
FSSNX35.92-0.18
-0.50%
Fidelity Small Cap Index
HFCIX36.31-0.20
-0.55%
Hennessy Focus Institutional
FTDZX204.61-3.72
-1.79%
Franklin Biotechnology Discovery Adv